share_log

EFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW) Sees Significant Decline in Short Interest

Financial News Live ·  Jan 2, 2023 11:31

eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) was the recipient of a significant decrease in short interest in December. As of December 15th, there was short interest totalling 26,800 shares, a decrease of 23.9% from the November 30th total of 35,200 shares. Based on an average trading volume of 16,000 shares, the days-to-cover ratio is presently 1.7 days.

eFFECTOR Therapeutics Price Performance

NASDAQ EFTRW remained flat at $0.16 on Friday. The company has a fifty day moving average of $0.13 and a 200-day moving average of $0.17. eFFECTOR Therapeutics has a fifty-two week low of $0.04 and a fifty-two week high of $0.99.

Featured Stories

  • Get a free copy of the StockNews.com research report on eFFECTOR Therapeutics (EFTRW)
  • MarketBeat: Week in Review 12/26 – 12/30
  • The Dogs Of Tech: It's Time For A Bite Of These Stocks
  • Does This Acquisition Make Microsoft a Bear Market Buy?
  • Is Kintara Therapeutics A Hidden Gem?
  • Should You Warm up to Generac Stock for the Winter?

Receive News & Ratings for eFFECTOR Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eFFECTOR Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment